CPT code 36825 represents the surgical creation of an arteriovenous fistula using an autogenous vein graft to provide vascular access for hemodialysis. As a foundational procedure for patients with end-stage kidney disease, this code captures a key step in chronic dialysis care and factors into facility and provider planning for vascular surgery services. Nationally, access creation rates, practice patterns, and reimbursement for AVF procedures influence capacity for dialysis access and downstream care coordination.

Key payers in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, typical sites of service, and the service type. The publication also summarizes what to expect in benchmarking and policy-oriented sections: utilization benchmarks, coding and billing considerations, and relevant updates affecting surgical vascular access reimbursement. Where specific payer policies or local coverage determinations apply, those details are signposted for readers to consult payer resources directly.

This executive summary equips clinicians, billing staff, and policy analysts with an understanding of what CPT code 36825 documents, why it matters in the national dialysis care pathway, and which payers are commonly involved in coverage and payment for this service.